Wells Fargo’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17M | Sell |
84,901
-47,735
| -36% | -$9.44M | ﹤0.01% | 1634 |
|
|
2025
Q4 | $25.1M | Buy |
132,636
+17,459
| +15% | +$3.35M | ﹤0.01% | 1343 |
|
|
2025
Q3 | $20.4M | Buy |
115,177
+101,936
| +770% | +$15.2M | ﹤0.01% | 1459 |
|
|
2025
Q2 | $1.51M | Buy |
13,241
+436
| +3% | +$46.6K | ﹤0.01% | 3428 |
|
|
2025
Q1 | $1.35M | Buy |
12,805
+1,585
| +14% | +$179K | ﹤0.01% | 3463 |
|
|
2024
Q4 | $1.2M | Buy |
11,220
+2,570
| +30% | +$291K | ﹤0.01% | 3574 |
|
|
2024
Q3 | $866K | Sell |
8,650
-161
| -2% | -$16.2K | ﹤0.01% | 3641 |
|
|
2024
Q2 | $742K | Buy |
8,811
+1,961
| +29% | +$156K | ﹤0.01% | 3677 |
|
|
2024
Q1 | $501K | Buy |
6,850
+1,170
| +21% | +$86.3K | ﹤0.01% | 3891 |
|
|
2023
Q4 | $406K | Buy |
5,680
+1,169
| +26% | +$69K | ﹤0.01% | 4004 |
|
|
2023
Q3 | $270K | Sell |
4,511
-3,352
| -43% | -$221K | ﹤0.01% | 4167 |
|
|
2023
Q2 | $567K | Buy |
7,863
+3,721
| +90% | +$279K | ﹤0.01% | 3850 |
|
|
2023
Q1 | $305K | Buy |
4,142
+2,140
| +107% | +$152K | ﹤0.01% | 4171 |
|
|
2022
Q4 | $134K | Sell |
2,002
-2,270
| -53% | -$148K | ﹤0.01% | 4396 |
|
|
2022
Q3 | $230K | Sell |
4,272
-378
| -8% | -$22.2K | ﹤0.01% | 4165 |
|
|
2022
Q2 | $259K | Sell |
4,650
-30,143
| -87% | -$1.71M | ﹤0.01% | 4145 |
|
|
2022
Q1 | $2.44M | Sell |
34,793
-24,791
| -42% | -$1.8M | ﹤0.01% | 3102 |
|
|
2021
Q4 | $5.74M | Sell |
59,584
-10,983
| -16% | -$1.01M | ﹤0.01% | 2430 |
|
|
2021
Q3 | $6.13M | Buy |
70,567
+12,471
| +21% | +$965K | ﹤0.01% | 2647 |
|
|
2021
Q2 | $4.75M | Sell |
58,096
-8,401
| -13% | -$699K | ﹤0.01% | 2919 |
|
|
2021
Q1 | $6.32M | Buy |
66,497
+10,025
| +18% | +$948K | ﹤0.01% | 2609 |
|
|
2020
Q4 | $3.5M | Sell |
56,472
-30,807
| -35% | -$1.76M | ﹤0.01% | 3050 |
|
|
2020
Q3 | $5.19M | Sell |
87,279
-32,303
| -27% | -$2.2M | ﹤0.01% | 2462 |
|
|
2020
Q2 | $8.34M | Sell |
119,582
-30,735
| -20% | -$1.95M | ﹤0.01% | 2007 |
|
|
2020
Q1 | $6.82M | Buy |
150,317
+68,141
| +83% | +$3.86M | ﹤0.01% | 1998 |
|
|
2019
Q4 | $5.35M | Sell |
82,176
-24,443
| -23% | -$1.63M | ﹤0.01% | 2508 |
|
|
2019
Q3 | $6.62M | Buy |
106,619
+4,107
| +4% | +$258K | ﹤0.01% | 2297 |
|
|
2019
Q2 | $7.3M | Buy |
102,512
+1,898
| +2% | +$140K | ﹤0.01% | 2220 |
|
|
2019
Q1 | $7.89M | Sell |
100,614
-554,585
| -85% | -$42M | ﹤0.01% | 2123 |
|
|
2018
Q4 | $55.5M | Buy |
655,199
+225,254
| +52% | +$24M | 0.02% | 768 |
|
|
2018
Q3 | $73.6M | Sell |
429,945
-40,927
| -9% | -$6.17M | 0.02% | 723 |
|
|
2018
Q2 | $60.9M | Buy |
470,872
+13,339
| +3% | +$1.49M | 0.02% | 814 |
|
|
2018
Q1 | $47.1M | Sell |
457,533
-82,574
| -15% | -$8.17M | 0.01% | 933 |
|
|
2017
Q4 | $46.1M | Sell |
540,107
-1,843
| -0.3% | -$160K | 0.01% | 932 |
|
|
2017
Q3 | $46M | Buy |
541,950
+36,101
| +7% | +$2.86M | 0.01% | 914 |
|
|
2017
Q2 | $38.3M | Buy |
505,849
+16,706
| +3% | +$1.17M | 0.01% | 1002 |
|
|
2017
Q1 | $32.3M | Sell |
489,143
-809,327
| -62% | -$53.2M | 0.01% | 1101 |
|
|
2016
Q4 | $82.3M | Sell |
1,298,470
-176,268
| -12% | -$11.1M | 0.03% | 586 |
|
|
2016
Q3 | $93.9M | Buy |
1,474,738
+224,342
| +18% | +$16.5M | 0.03% | 532 |
|
|
2016
Q2 | $93M | Sell |
1,250,396
-94,850
| -7% | -$7.04M | 0.04% | 494 |
|
|
2016
Q1 | $89.9M | Buy |
1,345,246
+464,516
| +53% | +$28.2M | 0.04% | 504 |
|
|
2015
Q4 | $59.6M | Buy |
880,730
+506,991
| +136% | +$31.3M | 0.02% | 680 |
|
|
2015
Q3 | $20M | Buy |
373,739
+123,788
| +50% | +$7.51M | 0.01% | 1304 |
|
|
2015
Q2 | $15.7M | Sell |
249,951
-23,014
| -8% | -$1.26M | 0.01% | 1543 |
|
|
2015
Q1 | $13.1M | Buy |
272,965
+42,994
| +19% | +$1.65M | 0.01% | 1640 |
|
|
2014
Q4 | $7.63M | Sell |
229,971
-64,789
| -22% | -$2.11M | ﹤0.01% | 2016 |
|
|
2014
Q3 | $8.64M | Sell |
294,760
-232,128
| -44% | -$7.71M | ﹤0.01% | 1903 |
|
|
2014
Q2 | $20.5M | Buy |
526,888
+65,229
| +14% | +$2.65M | 0.01% | 1270 |
|
|
2014
Q1 | $19.4M | Buy |
461,659
+164,144
| +55% | +$6.84M | 0.01% | 1287 |
|
|
2013
Q4 | $9.76M | Sell |
297,515
-35,441
| -11% | -$1.15M | ﹤0.01% | 1740 |
|
|
2013
Q3 | $8.99M | Buy |
332,956
+55,740
| +20% | +$1.57M | ﹤0.01% | 1726 |
|
|
2013
Q2 | $6.47M | Buy |
+277,216
| New | +$4.99M | ﹤0.01% | 1907 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Wells Fargo's LGND Position: Q1 2026 in Review
Wells Fargo reduced its Ligand Pharmaceuticals (LGND) stake by 36% in Q1 2026, selling an estimated $9.44M and leaving 84,901 shares worth $17M. The position accounts for ﹤0.01% of the portfolio, ranked #1634.
Wells Fargo first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $93.9M in Q3 2016. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Wells Fargo held 84,901 shares of Ligand Pharmaceuticals worth $17M as of Q1 2026.
- Wells Fargo sold 47,735 Ligand Pharmaceuticals shares in Q1 2026, an estimated $9.44M.
- Ligand Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1634 holding.
- Wells Fargo first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Ligand Pharmaceuticals position peaked at $93.9M in Q3 2016.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.